MACB CKD Task Force updated recommendations for reporting estimated glomerular filtration rate and albuminuria in...

Area of Science:

• Clinical Biochemistry
• Nephrology
• Public Health

Background:

• Chronic kidney disease (CKD) poses significant public health risks, necessitating accurate laboratory diagnostics.
• Laboratory assessment of CKD in Malaysia lacked standardization prior to national recommendations.
• International guidelines from KDIGO and NICE have recently updated CKD diagnosis and management strategies.

Purpose of the Study:

• To update the Malaysian national recommendation for laboratory diagnosis and reporting of CKD.
• To align laboratory practices with the latest international evidence-based guidelines.
• To improve the accuracy and consistency of CKD assessment in Malaysia.

Main Methods:

• Review and update of the Malaysian Association of Clinical Biochemistry CKD (MACB-CKD) Task Force recommendations.
• Incorporation of recent updates from Kidney Disease: Improving Global Outcomes (KDIGO) and National Institute for Health and Care Excellence (NICE) guidelines.
• Focus on critical areas: estimated glomerular filtration rate (eGFR), albuminuria assessment, and risk stratification using tools like the Kidney Failure Risk Equation (KFRE).

Main Results:

• Revised recommendations for laboratory reporting of eGFR and urine albumin.
• Enhanced guidance for laboratory professionals on CKD diagnosis and management.
• Alignment of national standards with current international best practices.

Conclusions:

• Updated Malaysian guidelines provide a standardized approach to laboratory diagnosis of CKD.
• These revisions support optimal patient care by integrating the latest evidence.
• The updated recommendations aim to improve the detection and management of CKD nationwide.